vaccine comprising engineered mouse AMHR2-ED protein (NCI/University of Texas at San Antonio)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevaccine comprising engineered mouse AMHR2-ED protein (NCI/University of Texas at San Antonio)

Drug Alias Nameovarian cancer vaccine (National Cancer Institute)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionAnti-Mullerian hormone receptor II antagonists

TargetsAnti-Mullerian hormone receptor II

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Texas System National Cancer Institute

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A